We studied whether creatine kinase appearance in venous effluent was specific for, and quantitatively proportional to, the amount of loss of functioning myocardium. Cell viability was determined by simultaneously monitoring tissue 42K content and mechanical performance during anoxia and reoxygenation in isolated, arterially perfused, interventricular rabbit septa. The septa were paced at 42 beats/min and perfused at 1.8 ml/min per g tissue with a modified Tyrode solution at 28°C. Net total creatine kinase losses of 5.3±2.7, 20.6±7.2, 55.3±7.6, and 110.7±27.1 IU/g dry wt (mean±SEM) were observed after 20, 30, 40, and 60 min of anoxia, respectively. Maximum 42K losses during the same intervals of anoxia were 16.8±3.4, 38.3±2.9, 47.0±1.4, and 84.3±14.8 mmol K+/kg dry wt and correlated with creatine kinase losses, r = 0.97. Upon reoxygenation, 42K content returned to a new plateau which was expressed as a percentage of decrease from control content. These unrecovered 42K losses were −2.7±0.9, 0.7±2.9, 6.6±1.9, and 14.0±6.5% after 20, 30, 40, and 60 min of anoxia, respectively, and correlated with the creatine kinase loss, r = 0.97. Net loss of developed tension after reoxygenation was 9.0±2.3, 26.7±17.9, 31.7±1.1, and 60.7±8.8% of control after these anoxic intervals and correlated with creatine kinase loss, r = 0.92. The small enzyme loss that occurred after 20 min anoxia without evidence for irreversible loss of cell function was ≅0.1% of total tissue enzyme content. The significant correlation of enzyme loss with the irreversible losses of potassium content and contractile performance supported the hypothesis that creatine kinase appearance in the venous effluent was the result of cell death.
Gary L. Conrad, Eric E. Rau, Kenneth I. Shine
Title and authors | Publication | Year |
---|---|---|
Cardiac Positron Emission Tomography
FM Bengel, T Higuchi, MS Javadi, R Lautamäki |
Journal of the American College of Cardiology | 2009 |
Physiological Basis for Potassium ( 39 K) Magnetic Resonance Imaging of the Heart
DS Fieno, RJ Kim, WG Rehwald, RM Judd |
Circulation research | 1999 |
Myonecrosis After Revascularization Procedures
RM Califf, AE Abdelmeguid, RE Kuntz, JJ Popma, CJ Davidson, EA Cohen, NS Kleiman, KW Mahaffey, EJ Topol, CJ Pepine, RJ Lipicky, CB Granger, RA Harrington, BE Tardiff, BS Crenshaw, RP Bauman, BD Zuckerman, BR Chaitman, JA Bittl, EM Ohman |
Journal of the American College of Cardiology | 1998 |
Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma
Y Ishikawa, JE Saffitz, TL Mealman, AM Grace, R Roberts |
Clinical chemistry | 1997 |
Assessment of left ventricular dysfunction by nuclear cardiology
JA Melin, W Wijns, JL Vanoverschelde, GR Heyndrickx |
Cardiovascular Drugs and Therapy | 1994 |
Contractile failure in early myocardial ischemia: Models and mechanisms
RN Gasser, W Klein |
Cardiovascular Drugs and Therapy | 1994 |
Twenty-four-hour quantitative thallium imaging for predicting beneficial revascularization
J Taki, K Nakajima, H Bunko, M Kawasuji, N Tonami, K Hisada |
European Journal of Nuclear Medicine | 1994 |
Myocardial Response to Acute Injury
JR Parratt |
1992 | |
Myocardial viability. What does it mean and how do we measure it?
KL Gould |
Circulation | 1991 |
PTCA An Investigational Tool and a Non-Operative Treatment of Acute Ischemia
PW Serruys, R Simon, KJ Beatt |
1990 | |
Pathobiology of Cardiovascular Injury
HL Stone, WB Weglicki |
1985 | |
Potassium and the heart
PA Poole-Wilson |
Clinics in Endocrinology and Metabolism | 1984 |
Myocardial ischemia: ionic events in ischemia and anoxia
KI Shine |
The American Journal of Pathology | 1981 |